Cargando…

G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor

A series of G(s) protein peptidomimetics were designed and synthesised based on the published X-ray crystal structure of the active state β(2)-adrenergic receptor (β(2)AR) in complex with the G(s) protein (PDB 3SN6). We hypothesised that such peptidomimetics may function as allosteric modulators tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyhus, Lotte-Emilie, Danielsen, Mia, Bengtson, Nina Smidt, Ben Achim Kunze, Micha, Kubiak, Xavier, Sminia, Tjerk J., Løper, Jacob Hartvig, Tran, Phuong Thu, Lindorff-Larsen, Kresten, Rasmussen, Søren G. F., Mathiesen, Jesper Mosolff, Pedersen, Daniel Sejer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077236/
https://www.ncbi.nlm.nih.gov/pubmed/35542596
http://dx.doi.org/10.1039/c7ra11713b
_version_ 1784702077983784960
author Boyhus, Lotte-Emilie
Danielsen, Mia
Bengtson, Nina Smidt
Ben Achim Kunze, Micha
Kubiak, Xavier
Sminia, Tjerk J.
Løper, Jacob Hartvig
Tran, Phuong Thu
Lindorff-Larsen, Kresten
Rasmussen, Søren G. F.
Mathiesen, Jesper Mosolff
Pedersen, Daniel Sejer
author_facet Boyhus, Lotte-Emilie
Danielsen, Mia
Bengtson, Nina Smidt
Ben Achim Kunze, Micha
Kubiak, Xavier
Sminia, Tjerk J.
Løper, Jacob Hartvig
Tran, Phuong Thu
Lindorff-Larsen, Kresten
Rasmussen, Søren G. F.
Mathiesen, Jesper Mosolff
Pedersen, Daniel Sejer
author_sort Boyhus, Lotte-Emilie
collection PubMed
description A series of G(s) protein peptidomimetics were designed and synthesised based on the published X-ray crystal structure of the active state β(2)-adrenergic receptor (β(2)AR) in complex with the G(s) protein (PDB 3SN6). We hypothesised that such peptidomimetics may function as allosteric modulators that target the intracellular G(s) protein binding site of the β(2)AR. Peptidomimetics were designed to mimic the 15 residue C-terminal α-helix of the G(s) protein and were pre-organised in a helical conformation by (i, i + 4)-stapling using copper catalysed azide alkyne cycloaddition. Linear and stapled peptidomimetics were analysed by circular dichroism (CD) and characterised in a membrane-based cAMP accumulation assay and in a bimane fluorescence assay on purified β(2)AR. Several peptidomimetics inhibited agonist isoproterenol (ISO) induced cAMP formation by lowering the ISO maximal efficacy up to 61%. Moreover, some peptidomimetics were found to significantly decrease the potency of ISO up to 39-fold. In the bimane fluorescence assay none of the tested peptidomimetics could stabilise an active-like conformation of β(2)AR. Overall, the obtained pharmacological data suggest that some of the peptidomimetics may be able to compete with the native G(s) protein for the intracellular binding site to block ISO-induced cAMP formation, but are unable to stabilise an active-like receptor conformation.
format Online
Article
Text
id pubmed-9077236
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90772362022-05-09 G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor Boyhus, Lotte-Emilie Danielsen, Mia Bengtson, Nina Smidt Ben Achim Kunze, Micha Kubiak, Xavier Sminia, Tjerk J. Løper, Jacob Hartvig Tran, Phuong Thu Lindorff-Larsen, Kresten Rasmussen, Søren G. F. Mathiesen, Jesper Mosolff Pedersen, Daniel Sejer RSC Adv Chemistry A series of G(s) protein peptidomimetics were designed and synthesised based on the published X-ray crystal structure of the active state β(2)-adrenergic receptor (β(2)AR) in complex with the G(s) protein (PDB 3SN6). We hypothesised that such peptidomimetics may function as allosteric modulators that target the intracellular G(s) protein binding site of the β(2)AR. Peptidomimetics were designed to mimic the 15 residue C-terminal α-helix of the G(s) protein and were pre-organised in a helical conformation by (i, i + 4)-stapling using copper catalysed azide alkyne cycloaddition. Linear and stapled peptidomimetics were analysed by circular dichroism (CD) and characterised in a membrane-based cAMP accumulation assay and in a bimane fluorescence assay on purified β(2)AR. Several peptidomimetics inhibited agonist isoproterenol (ISO) induced cAMP formation by lowering the ISO maximal efficacy up to 61%. Moreover, some peptidomimetics were found to significantly decrease the potency of ISO up to 39-fold. In the bimane fluorescence assay none of the tested peptidomimetics could stabilise an active-like conformation of β(2)AR. Overall, the obtained pharmacological data suggest that some of the peptidomimetics may be able to compete with the native G(s) protein for the intracellular binding site to block ISO-induced cAMP formation, but are unable to stabilise an active-like receptor conformation. The Royal Society of Chemistry 2018-01-09 /pmc/articles/PMC9077236/ /pubmed/35542596 http://dx.doi.org/10.1039/c7ra11713b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Boyhus, Lotte-Emilie
Danielsen, Mia
Bengtson, Nina Smidt
Ben Achim Kunze, Micha
Kubiak, Xavier
Sminia, Tjerk J.
Løper, Jacob Hartvig
Tran, Phuong Thu
Lindorff-Larsen, Kresten
Rasmussen, Søren G. F.
Mathiesen, Jesper Mosolff
Pedersen, Daniel Sejer
G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
title G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
title_full G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
title_fullStr G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
title_full_unstemmed G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
title_short G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
title_sort g(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077236/
https://www.ncbi.nlm.nih.gov/pubmed/35542596
http://dx.doi.org/10.1039/c7ra11713b
work_keys_str_mv AT boyhuslotteemilie gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT danielsenmia gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT bengtsonninasmidt gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT benachimkunzemicha gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT kubiakxavier gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT sminiatjerkj gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT løperjacobhartvig gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT tranphuongthu gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT lindorfflarsenkresten gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT rasmussensørengf gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT mathiesenjespermosolff gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor
AT pedersendanielsejer gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor